Page 1 of Clinical Trials for Lytix Biopharma AS [SPONSOR-COLLABORATORS], 4 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma
Last Updated: January 10, 2012
Condition(s): Carcinoma
2
Recruiting
Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour
Last Updated: November 28, 2011
Condition(s): Cancer With Transdermal Accessible Tumour
3
Completed
A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection
Last Updated: February 15, 2011
Condition(s): Gram-positive, Skin Infections; Mild Eczema/Dermatoses; Atopic Dermatitis
4
Completed
A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA)
Last Updated: June 7, 2011
Condition(s): Nasal Carriers MRSA

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Lytix+Biopharma+AS

Page 1 of Clinical Trials for Lytix Biopharma AS [SPONSOR-COLLABORATORS], 4 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About